Canada/Ottawa:
Apotex Inc., a Toronto, Ontario establishment, recalls certain batch/lots of the APO-Metformin ER Diabetes medication from the Canadian marketplace due to levels of Nitrosamines (“NDMA”) in excess of Canadian health regulations and consequential long-term risk of certain forms of Cancer, all serious health and safety hazards.
HCSC: http://ht.ly/O6Bt30qfPEy
Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72287a-eng.php
Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following medications are subject to this recall:
Filed under: Carcinogen (Cancer-causing), Drugs, Health Canada/Santé Canada, Home & Residential, Metformin, Nitrosamine | Tagged: Apotex Inc., carcinogen (Cancer) hazard, drug, HCSC, HCSC ID number: RA-72287, Health Canada, medication, Metformin, Nitrosamine contamination, Recalls Direct RIN: 12630-2020 | Leave a comment »